Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2024-12-19 Earnings Release
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Insider information, profit warning..
Earnings Release Classification · 100% confidence The document is a 'Stock Exchange Release' from Biohit Oyj dated December 19th, 2024, explicitly labeled as 'Insider information, profit warning'. It details a revision (lowering) of the company's revenue and operating profit guidance for the full year 2024. This type of announcement, which provides key financial updates outside of a full periodic report (like 10-K or IR), aligns best with the 'Earnings Release' (ER) definition, which covers initial announcements of periodical financial results or significant updates/warnings related to those results. Although it's a profit warning, it functions as an immediate financial performance update. FY 2024
2024-12-19 English
Biohit Oyj:n taloudellinen tiedottaminen ja yhtiökokous vuonna 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2120 characters) from Biohit Oyj detailing the schedule for their upcoming financial reporting dates and the planned date for their 2025 Annual General Meeting. It does not contain the actual financial reports or meeting materials themselves, but rather serves as a calendar notification for investors. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2024-11-27 Finnish
Biohit Oyj's Financial Reporting and Annual General Meeting in 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2236 characters) from Biohit Oyj detailing the planned schedule for future financial reporting and the date of the upcoming Annual General Meeting in 2025. It does not contain the actual financial reports or meeting materials themselves, but rather serves as a notification of when these documents will be published. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2024-11-27 English
Biohit Oyj's Financial Reporting an..
Report Publication Announcement Classification · 99% confidence The document is a press release from Biohit Oyj, dated November 27, 2024, detailing the schedule for its financial reporting (Year-end report, Half-year report) and the Annual General Meeting (AGM) for the year 2025. It explicitly announces *when* these reports and the meeting will occur, rather than containing the full content of those reports. Since it is an announcement about the publication schedule of future reports and the AGM date, it fits best under the category for announcing the publication of reports, which is Report Publication Announcement (RPA). It is too specific to be a general Regulatory Filing (RNS), and it is not the actual AGM material (AGM-R) or the actual financial reports (10-K, IR). The document length (2136 chars) also supports the RPA classification based on the 'MENU VS MEAL' rule.
2024-11-27 Finnish
Biohit Oyj's Financial Reporting an..
Report Publication Announcement Classification · 100% confidence The document is titled 'Biohit Oyj - Financial Calendar' and explicitly outlines the planned schedule for future financial reporting events in 2025, including the 'Financial Statement Release', the 'Annual Report', the 'Half-year financial report', and the date for the 'Annual General Meeting'. Since this document is an announcement detailing *when* future reports and meetings will occur, rather than being the report itself (like a 10-K or IR) or the AGM presentation (AGM-R), it fits best as an announcement regarding the publication of reports. Given the specific mention of the Annual General Meeting date, AGM-R is a possibility, but the primary focus is the entire financial calendar. However, the closest fit for an announcement detailing the schedule of future reports and meetings, especially when the AGM date is included, is often categorized under general regulatory announcements or specific report publication announcements. Since it announces the schedule for the Annual Report and the AGM, and it is a short announcement (2243 chars), it strongly aligns with the 'Report Publication Announcement' (RPA) category, which covers announcements about the timing of report releases. It is not the report itself, nor is it the AGM material, but the schedule announcement.
2024-11-27 English
Biohit Plc B-shares Subscribed with Stock Options I 2021B
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a press release from Biohit Oyj dated September 27, 2024, announcing the registration of new B-shares subscribed using option rights (Optio-oikeuksilla I 2021B). It details the number of shares issued (8,000), the subscription price (€1.00), the resulting total number of shares (15,181,593), and when the new shares will commence trading. This action directly relates to changes in the company's capital structure via the exercise of employee/investor options. This fits the definition of 'Capital/Financing Update' (CAP) as it details a capital structure change resulting from financing instruments (options). It is not a general earnings release (ER), a full annual report (10-K), or a simple notice of dividend (DIV). Since it is a specific announcement about capital changes resulting from option exercises, CAP is the most precise fit.
2024-09-27 Finnish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.